Richard C. Becker, MD

Original Contribution

Safety of Very Early Sheath Removal in Patients Treated With REG1 for Acute Coronary Syndromes: Insights From the RADAR Trial

10/31/2013

Jan H. Cornel , MD;

Richard C. Becker , MD;

John H. Alexander , MD, MHS;

Roxana Mehran , MD;

John P. Vavalle , MD;

Mauricio G. Cohen , MD, FACC;

Thomas J. Povsic , MD, PhD;

Christopher E. Buller , MD, FRCPC, FACC;

Steven L. Zelenkofske , DO;

Laura H. Aberle , BSPH;

Jaroslaw D. Kasprzak , MD;

Gilles Montalescot , MD, PhD;

Christoph Bode , MD;

Anticoagulation with REG1 allows for very early arterial sheath removal following cardiac catheterization without increasing the time to hemostasis or vascular access-site bleeding complications. Further studies are needed to determine...

Anticoagulation with REG1 allows...

10/31/2013

Journal of Invasive Cardiology

Review

Next-Generation Antithrombin Therapies

04/07/2009

Richard C. Becker , MD;

From the Duke Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Durham, North Carolina. The author discloses no conflicts of interest regarding the content herein. Manuscript submitted February 26, 2009 and accepted March 3,...

From the Duke Cardiovascular...

04/07/2009

Journal of Invasive Cardiology